JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5251
Invesco CEF Income Composite ETF
PCEF
$770M
| $68K | ﹤0.01% |
3,772
+3
| +0.1% | +$55 |
2015 Q4
28 quarters
|
|
5252
Superior Group of Companies
SGC
$207M
| $68K | ﹤0.01% |
6,678
+125
| +2% | +$1.21K |
2017 Q4
20 quarters
|
|
|
HLGN
5253
DELISTED
Heliogen, Inc.
HLGN
| $68K | ﹤0.01% |
2,794
+288
| +11% | +$13K |
2022 Q1
3 quarters
|
|
|
DIAX
5254
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $67K | ﹤0.01% |
+4,319
| New | +$65.5K |
2022 Q4
0 quarters
|
|
5255
CALL
Shift4
FOUR
$2.96B
| $67K | ﹤0.01% |
+1,200
| New | +$56.7K |
2022 Q4
0 quarters
|
|
|
VXRT
5256
DELISTED
Vaxart
VXRT
| $67K | ﹤0.01% |
70,548
+2,135
| +3% | +$3.02K |
2020 Q2
10 quarters
|
|
|
CISO
5257
CISO Global
CISO
$9.18M
| $66K | ﹤0.01% |
1,730
+89
| +5% | +$4.04K |
2022 Q1
3 quarters
|
|
5258
CALL
Establishment Labs
ESTA
$1.98B
| $66K | ﹤0.01% |
1,000
-6,300
| -86% | -$381K |
2022 Q3
1 quarter
|
|
|
EVV
5259
Eaton Vance Limited Duration Income Fund
EVV
$969M
| $66K | ﹤0.01% |
+7,000
| New | +$67.6K |
2022 Q4
0 quarters
|
|
5260
Nomura Holdings
NMR
$28.5B
| $66K | ﹤0.01% |
17,436
+3,609
| +26% | +$12.5K |
2018 Q3
17 quarters
|
|
|
PEO
5261
Adams Natural Resources Fund
PEO
$787M
| $66K | ﹤0.01% |
3,151
+187
| +6% | +$4.01K |
2015 Q4
28 quarters
|
|
|
APXH
5262
DELISTED
APEX HealthCare ETF
APXH
| $66K | ﹤0.01% |
7,499
+678
| +10% | +$5.83K |
2022 Q1
3 quarters
|
|
|
LONA
5263
LeonaBio Inc
LONA
$52.6M
| $65K | ﹤0.01% |
2,050
-54
| -3% | -$1.7K |
2020 Q4
8 quarters
|
|
5264
Fortuna Silver Mines
FSM
$3.3B
| $65K | ﹤0.01% |
+17,457
| New | +$57.6K |
2022 Q4
0 quarters
|
|
5265
Opus Small Cap Value ETF
OSCV
$628M
| $65K | ﹤0.01% |
+2,100
| New | +$65.5K |
2022 Q4
0 quarters
|
|
5266
SOPHiA GENETICS
SOPH
$698M
| $65K | ﹤0.01% |
31,392
+30,408
| +3,090% | +$68.3K |
2022 Q3
1 quarter
|
|
|
STRS
5267
DELISTED
STRATUS PPTYS INC
STRS
| $65K | ﹤0.01% |
3,423
+181
| +6% | +$4.34K |
2016 Q4
24 quarters
|
|
|
CPZ
5268
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$246M
| $64K | ﹤0.01% |
4,227
+3,843
| +1,001% | +$59.8K |
2022 Q3
1 quarter
|
|
5269
Focus Universal
FCUV
$3.04M
| $64K | ﹤0.01% |
38
+2
| +6% | +$5.18K |
2022 Q1
3 quarters
|
|
5270
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.33B
| $64K | ﹤0.01% |
+729
| New | +$64.3K |
2022 Q4
0 quarters
|
|
5271
iShares Global 100 ETF
IOO
$9.29B
| $64K | ﹤0.01% |
1,000
| – | – |
2017 Q2
22 quarters
|
|
5272
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$407M
| $64K | ﹤0.01% |
4,262
| – | – |
2013 Q2
38 quarters
|
|
5273
Neuronetics
STIM
$168M
| $64K | ﹤0.01% |
9,353
+1,394
| +18% | +$6.58K |
2018 Q3
17 quarters
|
|
5274
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$152M
| $64K | ﹤0.01% |
+2,600
| New | +$65K |
2022 Q4
0 quarters
|
|
5275
Impact Shares Womens Empowerment ETF Trading
WOMN
$57.7M
| $64K | ﹤0.01% |
+2,454
| New | +$69.2K |
2022 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.